News & Events about Adc Therapeutics Sa.
PharmaVentures establishes an office in Seoul to enhance access for South Korean biotechs PharmaVentures establishes an office in Seoul to enhance access for South Korean biotechs PR Newswire LONDON, March 29, 2023 LONDON, March 29, 2023 /PRNewswire/ -- PharmaVentures announces its new office in...
Shares of ADC Therapeutics SA (NYSE:ADCT Get Rating) have earned a consensus rating of Moderate Buy from the six ratings firms that are presently covering the company, MarketBeat reports. Two equities research analysts have rated the stock with a hold rating and four have assigned a buy rating to ...
Ticker Report
3 months ago
ADC Therapeutics SA (NYSE:ADCT Get Rating) Analysts at Capital One Financial issued their FY2027 earnings per share (EPS) estimates for shares of ADC Therapeutics in a research report issued to clients and investors on Wednesday, March 1st. Capital One Financial analyst N. Quibria ...
Ticker Report
4 months ago
ADC Therapeutics (NYSE:ADCT Get Rating) had its price objective cut by analysts at Morgan Stanley from $7.00 to $5.00 in a research report issued on Tuesday, Benzinga reports. The firm presently has an equal weight rating on the stock. Morgan Stanleys price target points...